MICARDIS Safety Questions, MICARDIS Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about MICARDIS. Our extensive database of MICARDIS adverse events and MICARDIS warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about MICARDIS

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




MICARDIS Safety Reports

Total MICARDIS reports: 472.
MICARDIS FDA safety alerts: No.
Reported deaths: 48    Reported hospitalizations: 315.
Take MICARDIS Side Effects Survey or Share Your MICARDIS Story. MICARDIS Usage.

Showing 1-75 of 472 Next >

Physician from UNITED STATES reported MICARDIS problem on Apr 07, 2006. Female patient was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: angioedema. MICARDIS dosage: unknown. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from UNITED STATES on June 15, 2006. Female patient was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: gout. MICARDIS dosage: 80 MG (80 MG, 1 IN 1 D), PO. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported MICARDIS problem on Aug 31, 2006. Female patient was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: angioedema. MICARDIS dosage: unknown. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Female patient, 59 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: thyroid operation. MICARDIS dosage: unknown. During the same period patient was treated with SINUS MEDICINE, HERBAL SUPPLEMENT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Feb 23, 2007. Male patient, weighting 129.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, depressed level of consciousness, hypoglycaemia, hypotension, ventricular tachycardia. MICARDIS dosage: unknown. During the same period patient was treated with AMLODIPINE, ALFAROL, FOSAMAC. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Feb 23, 2007. Male patient, weighting 151.0 lb, was diagnosed with hypertension, hyperuricaemia, hyperlipidaemia, gastritis, asthma, lung neoplasm malignant and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease. MICARDIS dosage: unknown. During the same period patient was treated with URINORM, LIPOVAS, TAGAMET, MEPTIN, URALYT, APLACE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Feb 23, 2007. Male patient, weighting 154.3 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: jaundice, liver disorder. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2007. Male patient, weighting 129.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, depressed level of consciousness, hypoglycaemia, hypotension, ventricular tachycardia. MICARDIS dosage: unknown. During the same period patient was treated with AMLODIPINE, ALFAROL, FOSAMAC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Feb 22, 2007. Male patient, weighting 108.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. MICARDIS dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

MICARDIS problem was reported by a Physician from FRANCE on Feb 21, 2007. Female patient, 71 years of age, was diagnosed with hypercholesterolaemia and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: muscle haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with SIMVASTATIN, EVISTA, LEVOTHYROXINE. Patient recovered.

Physician from UNITED KINGDOM reported MICARDIS problem on Feb 26, 2007. Male patient, weighting 165.3 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: peyronie's disease. MICARDIS dosage: unknown. During the same period patient was treated with IRBESARTAN, RAMIPRIL. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from BRAZIL on Mar 02, 2007. Male patient, weighting 269.0 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, renal failure. MICARDIS dosage: unknown. During the same period patient was treated with AGGRENOX, CLOPIDOGREL. Patient was hospitalized. Patient died on 11/06/2006.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Feb 27, 2007. Male patient, weighting 129.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, alcohol use, depressed level of consciousness, hypoglycaemia, hypotension, oral intake reduced, ventricular tachycardia. MICARDIS dosage: unknown. During the same period patient was treated with AMLODIPINE, ALFAROL, FOSAMAC. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from GERMANY on Mar 02, 2007. Male patient, weighting 165.3 lb, was diagnosed with hypertonia and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: muscle spasms, pulmonary embolism, thrombosis. MICARDIS dosage: unknown. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Mar 01, 2007. Female patient, weighting 119.0 lb, was diagnosed with hypertension, arrhythmia and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cholestasis, granulocytopenia. MICARDIS dosage: unknown. During the same period patient was treated with ASPENON. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from on Mar 02, 2007. Male patient, 61 years of age, was diagnosed with hypertension, blood cholesterol and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: bleeding time prolonged, epistaxis. MICARDIS dosage: unknown. During the same period patient was treated with ASPIRIN, CANDESARTAN, SIMVASTATIN. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Mar 02, 2007. Male patient, weighting 352.7 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, eye disorder. MICARDIS dosage: unknown. During the same period patient was treated with CALBLOCK. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Health Professional from on Mar 02, 2007. Male patient, 75 years of age, was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with NEXAVAR, THROMBO ASS, AMLODIPIN MESILATE. Patient died.

Physician from FRANCE reported MICARDIS problem on Mar 05, 2007. Male patient, 36 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: hypotension, neutropenia. MICARDIS dosage: unknown. During the same period patient was treated with ASPEGIC, AMLODIPINE, EUPRESSYL. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Mar 06, 2007. Female patient, weighting 113.5 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, renal failure acute. MICARDIS dosage: unknown. During the same period patient was treated with DIART, ASPIRIN, LIPITOR, ZANTAC. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Mar 06, 2007. Male patient, weighting 118.6 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hyperkalaemia, renal failure. MICARDIS dosage: unknown. During the same period patient was treated with NORVASC, DILTIAZEM, ASPIRIN, OMEPRAL, SIGMART, TICLOPIDINE. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Pharmacist from JAPAN on Mar 06, 2007. Male patient, weighting 114.6 lb, was diagnosed with hypertension, cerebral infarction and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, hyperkalaemia. MICARDIS dosage: unknown. During the same period patient was treated with NORVASC, CARDENALIN, ASPIRIN, SERMION. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Mar 02, 2007. Male patient, weighting 352.7 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, photopsia. MICARDIS dosage: unknown. During the same period patient was treated with CALBLOCK. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Mar 06, 2007. Male patient, weighting 118.6 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, hyperkalaemia, renal failure. MICARDIS dosage: unknown. During the same period patient was treated with NORVASC, DILTIAZEM, ASPIRIN, OMEPRAL, SIGMART, TICLOPIDINE. Patient was hospitalized. Patient recovered.

Physician from AUSTRALIA reported MICARDIS problem on Mar 06, 2007. Female patient, 75 years of age, was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, dehydration. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 06, 2007. Male patient, weighting 88.18 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, presyncope. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Mar 01, 2007. Female patient, weighting 119.0 lb, was diagnosed with hypertension, arrhythmia and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cholestasis, granulocytopenia. MICARDIS dosage: unknown. During the same period patient was treated with ASPENON. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Mar 13, 2007. Male patient, 36 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cholecystitis. MICARDIS dosage: unknown. During the same period patient was treated with ALDACTONE, ADALAT, TANATRIL, CARDENALIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Feb 27, 2007. Male patient, weighting 129.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, depressed level of consciousness, hypoglycaemia, hypotension, ventricular tachycardia. MICARDIS dosage: unknown. During the same period patient was treated with AMLODIN, ALFAROL, FOSAMAC. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from GERMANY on Mar 12, 2007. Male patient, weighting 183.0 lb, was diagnosed with hypertension, myocardial infarction, stress cardiomyopathy and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: abnormal faeces, nasal discomfort, parosmia, rhinalgia. MICARDIS dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, SIMVASTATIN, WARFARIN. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Feb 27, 2007. Male patient, weighting 129.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: acute myocardial infarction, depressed level of consciousness, feeling hot, hypoglycaemia, hypotension, ventricular tachycardia. MICARDIS dosage: unknown. During the same period patient was treated with AMLODIN, ALFAROL, FOSAMAC. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from GERMANY on Mar 14, 2007. Female patient, weighting 200.6 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, atrioventricular block complete, syncope, tachycardia, torsade de pointes, vertigo. MICARDIS dosage: 80 MG TELMISARTAN, 12,5 MG HCT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MICARDIS problem on Mar 15, 2007. Male patient, weighting 82.45 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, presyncope. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from MALAYSIA on Mar 12, 2007. Female patient, weighting 121.3 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: renal failure chronic. MICARDIS dosage: unknown. During the same period patient was treated with AGGRENOX, CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Mar 13, 2007. Male patient, weighting 352.7 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, photopsia. MICARDIS dosage: unknown. During the same period patient was treated with CALBLOCK. Patient recovered.

MICARDIS problem was reported by a Physician from on Mar 08, 2007. Female patient, 73 years of age, weighting 172.0 lb, was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: dermatitis psoriasiform. MICARDIS dosage: unknown. During the same period patient was treated with TAREG, ATACAND. Patient was hospitalized. Patient recovered.

Pharmacist from JAPAN reported MICARDIS problem on Mar 14, 2007. Male patient, weighting 114.6 lb, was diagnosed with hypertension, cerebral infarction and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, hyperkalaemia. MICARDIS dosage: unknown. During the same period patient was treated with NORVASC, CARDENALIN, ASPIRIN, SERMION. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Dec 27, 2006. Female patient, weighting 94.80 lb, was diagnosed with hypertension, reflux oesophagitis, anaemia, epilepsy, asthma, gastritis, hypoaesthesia and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: asthma, blood creatine phosphokinase increased, myalgia, pancreatitis acute. MICARDIS dosage: unknown. During the same period patient was treated with TAKEPRON, LASIX, TETUCUR S, CLONAZEPAM, NORVASC, THEOLONG, SUCRALFATE, CYANOCOBALAMIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Mar 20, 2007. Male patient, weighting 118.6 lb, was diagnosed with diabetes mellitus, acute myocardial infarction, prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, renal failure. MICARDIS dosage: unknown. During the same period patient was treated with NORVASC, DILTIAZEM, ASPIRIN, OMEPRAL, SIGMART, TICLOPIDINE. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Mar 20, 2007. Female patient, weighting 113.5 lb, was diagnosed with hypertension, cardiac failure, cerebral infarction, prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia, renal failure acute. MICARDIS dosage: unknown. During the same period patient was treated with DIART, ASPIRIN, LIPITOR, ZANTAC. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MICARDIS problem on Mar 08, 2007. Female patient, weighting 388.0 lb, was diagnosed with cardiovascular disorder, cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: renal failure acute. MICARDIS dosage: unknown. During the same period patient was treated with DILTIAZEM, SIMVASTATIN, ASPIRIN, CALCIDRINE, BICARBONATE, INHALERS. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Health Professional from UNITED STATES on Mar 23, 2007. Female patient, 56 years of age, weighting 224.9 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cough, hypersensitivity, pneumonia aspiration, respiratory arrest, respiratory distress, tachycardia, troponin increased, vasoconstriction. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from reported MICARDIS problem on Mar 21, 2007. Male patient, weighting 187.4 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: infective tenosynovitis, tendon rupture. MICARDIS dosage: 40 MG TELMISARTAN, 12,5 MG HCT. Patient recovered.

MICARDIS problem was reported by a Pharmacist from GERMANY on Feb 20, 2007. Female patient, weighting 134.5 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cardiovascular disorder, syncope. MICARDIS dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MICARDIS problem on Mar 29, 2007. Female patient, weighting 388.0 lb, was diagnosed with cardiovascular disorder, cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: renal failure acute. MICARDIS dosage: unknown. During the same period patient was treated with DILTIAZEM, SIMVASTATIN, ASPIRIN, CALCIDRINE, BICARBONATE, INHALERS. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from BRAZIL on Nov 14, 2006. Male patient, weighting 269.0 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, renal failure, ventricular fibrillation. MICARDIS dosage: unknown. During the same period patient was treated with AGGRENOX, CLOPIDOGREL. Patient was hospitalized. Patient died on 11/06/2006.

Consumer or non-health professional from UNITED STATES reported MICARDIS problem on Mar 27, 2007. Male patient, 55 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis. MICARDIS dosage: unknown. During the same period patient was treated with AVODART. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from MALAYSIA on Mar 28, 2007. Female patient, weighting 121.3 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, renal failure acute, renal failure chronic. MICARDIS dosage: unknown. During the same period patient was treated with AGGRENOX, CLOPIDOGREL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported MICARDIS problem on Apr 03, 2007. Female patient, weighting 176.4 lb, was diagnosed with cardiovascular disorder, cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: renal failure acute. MICARDIS dosage: unknown. During the same period patient was treated with DILTIAZEM, SIMVASTATIN, ASPIRIN, CALCIDRINE, BICARBONATE, INHALERS. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from AUSTRALIA on Mar 29, 2007. Male patient, 31 years of age, was diagnosed with essential hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: bronchospasm, urticaria. MICARDIS dosage: unknown. Patient recovered.

Physician from GERMANY reported MICARDIS problem on Mar 29, 2007. Male patient, 58 years of age, weighting 207.2 lb, was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: fatigue, myoclonus, speech disorder, visual disturbance. MICARDIS dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from on Mar 28, 2007. Female patient, weighting 185.0 lb, was diagnosed with asthma, seasonal allergy and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: choking sensation, dyspnoea. MICARDIS dosage: unknown. During the same period patient was treated with FLOVENT, VENTOLIN, FLONASE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported MICARDIS problem on Apr 03, 2007. Male patient, weighting 81.57 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, presyncope. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from ITALY on Apr 04, 2007. Male patient, weighting 211.6 lb, was diagnosed with cardiovascular disorder, cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: angioedema. MICARDIS dosage: unknown. During the same period patient was treated with EFFEXOR, LORAZEPAM, ZANEDIP, GLUCOBAM, GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Apr 06, 2007. Female patient, weighting 119.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with CALBLOCK. Patient was hospitalized and became disabled. Patient recovered.

MICARDIS problem was reported by a Physician from on Apr 04, 2007. Male patient, 55 years of age, weighting 180.8 lb, was diagnosed with essential hypertension, dyspepsia and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: dyspepsia, fatigue, hepatocellular damage, jaundice hepatocellular, nausea. MICARDIS dosage: unknown. During the same period patient was treated with OMEPRAZOLE, ASPIRIN. Patient recovered.

Consumer or non-health professional from reported MICARDIS problem on Apr 05, 2007. Female patient, weighting 185.0 lb, was diagnosed with asthma, seasonal allergy and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: choking sensation, dyspnoea. MICARDIS dosage: unknown. During the same period patient was treated with FLOVENT, VENTOLIN, FLONASE. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from JAPAN on Apr 12, 2007. Male patient, weighting 119.0 lb, was diagnosed with renal hypertension, hyperlipidaemia and was treated with MICARDIS. MICARDIS dosage: unknown. During the same period patient was treated with BEZATOL. Patient died on 12/24/2006.

Consumer or non-health professional from JAPAN reported MICARDIS problem on Apr 17, 2007. Female patient, weighting 119.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with CALBLOCK. Patient was hospitalized and became disabled. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient, weighting 81.57 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, blood creatinine increased, blood urea increased, presyncope. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from reported MICARDIS problem on Apr 16, 2007. Female patient, 73 years of age, weighting 172.0 lb, was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: dermatitis psoriasiform. MICARDIS dosage: unknown. During the same period patient was treated with TAREG, ATACAND. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from JAPAN on Apr 17, 2007. Female patient, weighting 119.0 lb, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with CALBLOCK. Patient was hospitalized and became disabled. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Apr 18, 2007. Female patient, 62 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Consumer or non-health professional from JAPAN on Apr 25, 2007. Male patient, weighting 119.0 lb, was diagnosed with renal hypertension, hyperlipidaemia and was treated with MICARDIS. MICARDIS dosage: unknown. During the same period patient was treated with BEZATOL. Patient died on 12/24/2006.

Consumer or non-health professional from reported MICARDIS problem on Apr 18, 2007. Male patient, weighting 160.9 lb, was diagnosed with essential hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: anxiety, panic attack. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 141.1 lb, was diagnosed with hypertension, chest x-ray abnormal and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, pulmonary alveolar haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with TENORMIN, NORVASC, FLOMOX, KIRPRES, MUCOSOLVAN, MEDICON. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported MICARDIS problem on Apr 23, 2007. Female patient, 62 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, insulinoma. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from AUSTRALIA on Mar 06, 2007. Female patient, 75 years of age, was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: blood sodium increased, dehydration. MICARDIS dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on May 10, 2007. Female patient, weighting 160.9 lb, was diagnosed with hypertension, hypothyroidism, hyperlipidaemia, diabetes mellitus and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. MICARDIS dosage: unknown. During the same period patient was treated with INDERAL LA, THYRADIN S, SIMVASTATIN, DIBETOS B. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from UNITED STATES on May 09, 2007. Male patient, 55 years of age, was diagnosed with hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: nephrolithiasis. MICARDIS dosage: unknown. During the same period patient was treated with AVODART. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from MALAYSIA reported MICARDIS problem on May 10, 2007. Female patient, weighting 121.3 lb, was diagnosed with cerebrovascular accident prophylaxis and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer, renal failure acute, renal failure chronic. MICARDIS dosage: unknown. During the same period patient was treated with AGGRENOX, CLOPIDOGREL. Patient was hospitalized. Patient died.

MICARDIS problem was reported by a Physician from on May 10, 2007. Female patient, 57 years of age, weighting 191.8 lb, was diagnosed with prophylaxis, vitamin supplementation and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: pancytopenia, renal failure acute. MICARDIS dosage: unknown. During the same period patient was treated with GLUCOPHAGE, IMODIUM, LYTOS, ALIMTA, TARCEVA, GRANOCYTE, NEORECORMON, FOLIC ACID. Patient was hospitalized. Patient recovered.

Physician from AUSTRALIA reported MICARDIS problem on Apr 15, 2005. Female patient, weighting 171.3 lb, was diagnosed with osteoarthritis, hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. MICARDIS dosage: unknown. During the same period patient was treated with PANAMAX, ADALAT, ATENOLOL, NAPROSYN CR, BACTRIM. Patient was hospitalized. Patient recovered.

MICARDIS problem was reported by a Physician from AUSTRALIA on Apr 15, 2005. Female patient, weighting 171.3 lb, was diagnosed with osteoarthritis, hypertension and was treated with MICARDIS. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. MICARDIS dosage: unknown. During the same period patient was treated with PANAMAX, ADALAT, ATENOLOL, NAPROSYN CR, BACTRIM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported MICARDIS problem on May 17, 2007. Female patient, weighting 75.62 lb, was diagnosed with hypertension, diabetes mellitus, atrial fibrillation, cerebral infarction and was treated with MICARDIS. MICARDIS dosage: unknown. During the same period patient was treated with INSULIN, LASIX, WARFARIN, DIGOXIN, MILLIS, ASPIRIN, NOVORAPID. Patient was hospitalized. Patient died on 04/16/2007.

Showing 1-75 of 472 Next >

Ask Our Patient Community about MICARDIS

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin